| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $2.2B | $2.1B | $2.2B | 1.0% | -0.6% |
| Op. Income | $493M | $365M | -$2.9B | 35.1% | 117.0% |
| Gross Margin | 46.8% | 46.8% | 48.6% | 0.0pp | -1.8pp |
| Net Margin | 13.8% | 9.6% | -113.1% | 4.2pp | 126.9pp |
| EPS (Diluted) | $0.84 | $0.57 | $-7.24 | 47.4% | 111.6% |
| Free Cash Flow | $255M | $401M | $24M | -36.4% | 962.5% |
| Item | Amount |
|---|---|
| REVENUE | $2.2B |
| Cost of Revenue | $1.1B |
| GROSS PROFIT | $1.0B |
| R&D Expenses | $62M |
| Selling & Marketing | $186M |
| General & Administrative | $119M |
| SG&A Expenses | $305M |
| Other Expenses | $150M |
| Operating Expenses | $517M |
| Cost & Expenses | $1.7B |
| OPERATING INCOME | $493M |
| Interest Income | $0 |
| Interest Expense | $115M |
| Other Income/Expenses | -$105M |
| INCOME BEFORE TAX | $388M |
| Income Tax Expense | $91M |
| Net Income from Continuing Ops | $297M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $297M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $297M |
| D&A | $152M |
| EBIT | $503M |
| EBITDA | $655M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $2.2B |
| Cost of Revenue | $1.1B |
| GROSS PROFIT | $1.0B |
| R&D Expenses | $62M |
| Selling & Marketing | $186M |
| General & Administrative | $119M |
| SG&A Expenses | $305M |
| Other Expenses | $150M |
| Operating Expenses | $517M |
| Cost & Expenses | $1.7B |
| OPERATING INCOME | $493M |
| Interest Income | $0 |
| Interest Expense | $115M |
| Other Income/Expenses | -$105M |
| INCOME BEFORE TAX | $388M |
| Income Tax Expense | $91M |
| Net Income from Continuing Ops | $297M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $297M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $297M |
| D&A | $152M |
| EBIT | $503M |
| EBITDA | $655M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $297M |
| Depreciation & Amortization | $152M |
| Stock-Based Compensation | $43M |
| Deferred Income Tax | $90M |
| Other Non-Cash Items | $36M |
| Change in Working Capital | -$188M |
| OPERATING CASH FLOW | $430M |
| Capital Expenditure | -$175M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $2M |
| Other Investing Activities | -$18M |
| NET CASH FROM INVESTING | -$191M |
| Net Debt Issuance | -$129M |
| Common Stock Repurchased | -$21M |
| Common Dividends Paid | -$91M |
| Other Financing Activities | -$11M |
| NET CASH FROM FINANCING | -$252M |
| FREE CASH FLOW | $255M |
| Net Change in Cash | -$13M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $79M |
| Short-Term Investments | $0 |
| Net Receivables | $703M |
| Inventory | $0 |
| Other Current Assets | $302M |
| TOTAL CURRENT ASSETS | $1.1B |
| PP&E (Net) | $2.2B |
| Goodwill | $12.4B |
| Intangible Assets | $1.5B |
| Long-Term Investments | $983M |
| Tax Assets | $0 |
| Other Non-Current Assets | $9.2B |
| TOTAL NON-CURRENT ASSETS | $26.3B |
| TOTAL ASSETS | $27.4B |
| Account Payables | $1.2B |
| Short-Term Debt | $1.1B |
| Deferred Revenue | $1.0B |
| Other Current Liabilities | $223M |
| TOTAL CURRENT LIABILITIES | $3.5B |
| Long-Term Debt | $9.0B |
| Deferred Revenue NC | $89M |
| Deferred Tax Liabilities | $2.3B |
| Other Non-Current Liabilities | $1.0B |
| TOTAL NON-CURRENT LIABILITIES | $12.4B |
| TOTAL LIABILITIES | $15.8B |
| Common Stock | $0 |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $11.6B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$50M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $11.6B |
| Minority Interest | $0 |
| TOTAL EQUITY | $11.6B |
| TOTAL LIABILITIES & EQUITY | $27.4B |
| Total Debt | $10.1B |
| Net Debt | $10.0B |
